tiprankstipranks

Rigel Pharmaceuticals sees Q4 revenue $57.6M, consensus $47.42M

Rigel Pharmaceuticals sees Q4 revenue $57.6M, consensus $47.42M

While Rigel is still determining final results for the fourth quarter of 2024, the company expects to report fourth quarter total revenue of $57.6M, compared to $35.8M for the same period of 2023. Rigel expects to report fourth quarter net product sales of $46.5M, compared to $29.5M for the same period of 2023.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue